Pasar al contenido principal

RADIOBIOLOGIA EN LA TERAPIA DE PROTONES. BASES PARA LA COMBINACION DE LA TERAPIA DE PROTONES E INMUNOTERAPIA.

PID2019-104558RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO DE INVESTIGACION ENERGETICA MEDIOAMBIENTAL Y TECNOLOGICA (CIEMAT)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton Therapy

  • Ibáñez-Moragues, Marta
  • Fernández-Barahona, Irene
  • Santacruz, Rocío
  • Oteo, Marta
  • Luján-Rodríguez, Víctor M.
  • Muñoz-Hernando, María
  • Magro, Natalia
  • Lagares, Juan I.
  • Romero, Eduardo
  • España, Samuel
  • Espinosa-Rodríguez, Andrea
  • García-Díez, Miguel
  • Martínez-Nouvilas, Víctor
  • Sánchez-Tembleque, Víctor
  • Udías, José Manuel
  • Valladolid-Onecha, Víctor
  • Martín-Rey, Miguel Ángel
  • Almeida-Cordón, Edilia I.
  • Viñals i Onsès, Sílvia
  • Pérez, José Manuel
  • Fraile, Luis Mario
  • Herranz, Fernando
  • Morcillo, Miguel Ángel
Proton therapy allows the treatment of specific areas and avoids the surrounding tissues. However, this technique has uncertainties in terms of the distal dose fall-off. A promising approach to studying the proton range is the use of nanoparticles as proton-activatable agents that produce detectable signals. For this, we developed an iron oxide nanoparticle doped with Zn (IONP@Zn-cit) with a hydrodynamic size of 10 nm and stability in serum. Cytotoxicity, defined as half of the surveillance, was 100 μg Zn/mL in the U251 cell line. The effect on clonogenic cell death was tested after X-ray irradiation, which suggested a radioprotective effect of these nanoparticles at low concentrations (1–10 μg Zn/mL). To evaluate the production of positron emitters and prompt-gamma signals, IONP@Zn-cit was irradiated with protons, obtaining prompt-gamma signals at the lowest measured concentration (10 mg Zn/mL). Finally, 67Ga-IONP@Zn-cit showed accumulation in the liver and spleen and an accumulation in the tumor tissue of 0.95% ID/g in a mouse model of U251 cells. These results suggest the possibility of using Zn nanoparticles as proton-activatable agents to verify the range by prompt gamma detection and face the challenges of prompt gamma detection in a specific biological situation, opening different avenues to go forward in this field., This research was supported by projects B2017/BMD-3888 PRONTO-CM and S2022/BMD-7434 ASAP-CM, both funded by Comunidad de Madrid, and projects PID2019-104558RB-I00 and TED2021-130592B-I00, both funded by MCIN/ AEI/10.13039/501100011033., Peer reviewed